Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (529)	1/23/2000 12:22:00 AM
From: Pseudo Biologist	Read Replies (2) \| Respond to of 52153

Good point, add MLNM at 37 (but only 19 in the float according to Yahoo). The floats of MAXY and CALP should be a lot less than the 29 and 20 outstanding, respectively, making your point even stronger. How do you increase the supply? (1) secondaries: HGS, GLGC, MLNM at least have done or announced these or related financings recently (2) IPOs: MAXY and CALP are examples; SQNM, a sort-of, is coming soon, and so is Aclara, a CALP-like co. AFAIK. (3) "sector shift" Guess, should hold for now -g- PB